DD, the CFO got back to me the next day. His reply:
"As with all clinical trials, we are at the mercy of the sites as we have no direct control over the clinicians."
Is up to each investor what to decide about the state of the company. The "trial enrolment slowed" comment in the quarterly was begging for explaination, that's why I asked directly.
How a 40 person 5 day trial can take so long, and be delayed like this, really stretches the imagination.